Article
Dengue Virus Evolution under a Host-Targeted Antiviral.
Journal of virology - 1 May 2015
Plummer Emily, Buck Michael D, Sanchez Marisa, Greenbaum Jason A, Turner Julia, Grewal Rajvir, Klose Brennan, Sampath Aruna, Warfield Kelly L, Peters Bjoern, Ramstedt Urban, Shresta Sujan
Abstract excerpt
UNLABELLED: The host-targeted antiviral drug UV-4B reduces viral replication and promotes survival in a mouse model of experimental dengue virus (DENV) infection. UV-4B is an iminosugar that inhibits the α-glucosidase family of enzymes and subsequently the folding of glycosylated proteins, both viral and host. Here, we utilized next-generation sequencing to investigate evolution of a flavivirus under selective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
